secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001213900-22-081611
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dec 20, 2022: Allarity Therapeutics (ALLR) gets Nasdaq deficiency notice for MVPHS non-compliance
--------------------------------------------------------------------------------

- Nasdaq notice: MVPHS below $5M for 31 consecutive business days through Dec 19, 2022.
- Compliance period of 180 days until June 19, 2023; must close at $5M for 10 consecutive business days.
- If not compliant by deadline, company may face delisting from Nasdaq Global Market.
- Company intends to monitor MVPHS and evaluate available options to regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390022081611/0001213900-22-081611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390022081611/ea170617-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-081611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer